PubRank
Search
About
Rosemary O'Connor
Author PubWeight™ 37.54
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.
Neurobiol Aging
2010
2.32
2
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.
Breast Cancer Res
2013
1.92
3
Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.
J Neurochem
2005
1.67
4
Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction.
Circ Cardiovasc Interv
2011
1.62
5
Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth.
Mol Biol Cell
2005
1.36
6
Phosphorylation of RACK1 on tyrosine 52 by c-Abl is required for insulin-like growth factor I-mediated regulation of focal adhesion kinase.
J Biol Chem
2009
1.33
7
RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death.
J Biol Chem
2002
1.31
8
Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration.
Mol Cell Biol
2006
1.27
9
Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts.
Mol Cell Biol
2002
1.27
10
Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and beta1 integrin and for tumor cell proliferation and migration.
J Biol Chem
2008
1.19
11
The insulin-like growth factor-I-mTOR signaling pathway induces the mitochondrial pyrimidine nucleotide carrier to promote cell growth.
Mol Biol Cell
2007
1.16
12
RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251.
J Biol Chem
2004
1.10
13
Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level.
BMC Cancer
2008
1.03
14
Fluorescence-based cell viability screening assays using water-soluble oxygen probes.
J Biomol Screen
2003
1.01
15
Dynamic complex formation between HD-GYP, GGDEF and PilZ domain proteins regulates motility in Xanthomonas campestris.
Mol Microbiol
2012
1.01
16
Eukaryotic membrane protein overproduction in Lactococcus lactis.
Curr Opin Biotechnol
2005
0.97
17
Heme-binding protein HRG-1 is induced by insulin-like growth factor I and associates with the vacuolar H+-ATPase to control endosomal pH and receptor trafficking.
J Biol Chem
2009
0.97
18
Gene expression profiles in cells transformed by overexpression of the IGF-I receptor.
Oncogene
2005
0.95
19
The EphA3 receptor is expressed in a subset of rhabdomyosarcoma cell lines and suppresses cell adhesion and migration.
J Cell Biochem
2008
0.94
20
Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like growth factor I receptor mutated at tyrosines 1250 and 1251.
J Biol Chem
2004
0.94
21
Ribosomal 18 S RNA processing by the IGF-I-responsive WDR3 protein is integrated with p53 function in cancer cell proliferation.
J Biol Chem
2010
0.92
22
Insulin-like growth factor-1 activates Akt and Jun N-terminal kinases (JNKs) in promoting the survival of T lymphocytes.
Immunology
2002
0.92
23
EphA3 is induced by CD28 and IGF-1 and regulates cell adhesion.
Exp Cell Res
2004
0.91
24
RACK1 to the future--a historical perspective.
Cell Commun Signal
2013
0.90
25
Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB.
J Leukoc Biol
2008
0.90
26
PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome.
Mol Biol Cell
2013
0.88
27
Direct interaction between scaffolding proteins RACK1 and 14-3-3ζ regulates brain-derived neurotrophic factor (BDNF) transcription.
J Biol Chem
2011
0.88
28
A low-volume platform for cell-respirometric screening based on quenched-luminescence oxygen sensing.
Biosens Bioelectron
2004
0.86
29
RACK1 promotes neurite outgrowth by scaffolding AGAP2 to FAK.
Cell Signal
2013
0.84
30
Tim-4 inhibition of T-cell activation and T helper type 17 differentiation requires both the immunoglobulin V and mucin domains and occurs via the mitogen-activated protein kinase pathway.
Immunology
2011
0.83
31
Site-specific phosphorylation of the DNA damage response mediator rad9 by cyclin-dependent kinases regulates activation of checkpoint kinase 1.
PLoS Genet
2013
0.81
32
Serine phosphorylation of the insulin-like growth factor I (IGF-1) receptor C-terminal tail restrains kinase activity and cell growth.
J Biol Chem
2012
0.79
33
Erythrocyte survival is promoted by plasma and suppressed by a Bak-derived BH3 peptide that interacts with membrane-associated Bcl-X(L).
Blood
2002
0.78
34
Effects of RACK1 on cell migration and IGF-I signalling in cardiomyoctes are not dependent on an association with the IGF-IR.
Cell Signal
2007
0.78
35
A case report of spontaneous mutation (C33>U) in the iron-responsive element of L-ferritin causing hyperferritinemia-cataract syndrome.
Blood Cells Mol Dis
2009
0.77